Perspective - (2026) Volume 17, Issue 1
Received: 20-Jan-2026 , Manuscript No. JBP-26-32373; Editor assigned: 22-Jan-2026 , Pre QC No. JBP-26-32373; Reviewed: 05-Feb-2026 , QC No. JBP-26-32373; Revised: 12-Feb-2026 , Manuscript No. JBP-26-32373; Published: 19-Feb-2026 , DOI: 10.35248/2155-9597.26.17.590
Antibiotic resistance is the ability of bacteria to survive exposure to an antimicrobial drug that would normally inhibit their growth or eliminate them. It is a major concern in clinical medicine, veterinary practice, food production, and environmental microbiology. Antibiotics have transformed the treatment of bacterial infections, but their effectiveness can decline when bacterial populations acquire genetic characteristics that reduce their sensitivity to these medicines. Resistance may affect one antibiotic or several classes, depending on the mechanisms present within a bacterial strain.
Bacteria can develop resistance through genetic mutation or by obtaining resistance-associated genes from other bacteria. Mutations occur naturally during Deoxyribonucleic Acid (DNA) replication and may sometimes alter a protein involved in antibiotic activity. If a mutation allows a bacterium to survive treatment, that cell can reproduce and pass the altered genetic characteristic to its descendants. Over repeated generations, the proportion of resistant bacteria may increase, particularly when antibiotic exposure removes susceptible cells while resistant cells remain viable.
Horizontal gene transfer provides another major route for resistance development. Bacteria can exchange genetic material through several processes. Conjugation involves direct cell-to-cell transfer of DNA, frequently through plasmids. Transformation occurs when bacteria take up DNA fragments from their surroundings. Transduction involves bacteriophages transferring bacterial genetic material between cells. These mechanisms allow resistance-associated genes to move between bacterial populations and, in some circumstances, between different bacterial species. Plasmids are particularly important because they can carry multiple resistance genes on the same DNA molecule. A single plasmid may contain genes that reduce susceptibility to several antimicrobial classes. When such a plasmid is transferred to another bacterium, the recipient can acquire several resistance characteristics at once. Other mobile genetic structures, including transposons and integrons, can also contribute to the movement and accumulation of resistance genes.
Bacteria can resist antibiotics through several molecular mechanisms. One mechanism involves enzymes that chemically modify or destroy the antibiotic. Beta-lactamases, for example, can break down certain beta-lactam antibiotics before they reach their bacterial targets. Other enzymes can modify aminoglycosides and reduce their activity. The particular enzymes produced by a bacterium determine which antimicrobial compounds are affected.
Another mechanism involves changes to the antibiotic target. Many antibiotics work by binding to specific bacterial proteins or cellular structures. A mutation in the gene encoding the target can alter its shape and reduce antibiotic binding. Some bacteria can also acquire alternative versions of target proteins that continue to perform their normal biological functions while showing reduced sensitivity to a particular drug.
Changes in bacterial membranes can also influence antibiotic susceptibility. Some antibiotics must enter bacterial cells to reach their targets. Bacteria may reduce the number or activity of membrane channels through which antibiotics enter. In Gram-negative organisms, alterations in outer-membrane porins can decrease the movement of certain drugs into the cell. Reduced entry can therefore allow bacteria to survive concentrations that would normally be inhibitory.
Efflux pumps provide another resistance mechanism. These transport proteins move substances out of bacterial cells. When an efflux system recognizes an antibiotic, it can remove the compound before it reaches an effective concentration inside the cell. Some efflux pumps have relatively narrow substrate ranges, whereas others can transport several types of antimicrobial compounds. Increased activity of broad-range pumps can therefore contribute to resistance against multiple drug classes. Efflux pumps can therefore play an important role in the development and spread of multidrug resistance.
The use of antibiotics in human medicine has an important relationship with resistance. Antibiotics are effective against bacterial infections, but unnecessary use provides opportunities for resistant organisms to survive and spread. Antibiotic exposure creates selective pressure within bacterial populations. When a susceptible population is treated, sensitive cells may be inhibited or killed while resistant cells survive. The surviving bacteria can then multiply. Taking an antibiotic when a bacterial infection is not present may expose normal microbial communities to the drug without providing a therapeutic benefit. Similarly, using an inappropriate antibiotic, dose, or treatment duration can affect treatment success and microbial selection.
Citation: Calloway E (2026). Antibiotic Resistance: Genetic Mechanisms, Bacterial Adaptation, and Clinical Impact. J Bacteriol Parasitol. 17:590.
Copyright: © 2026 Calloway E. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution and reproduction in any medium, provided the original author and source are credited.